Background: Bovine spongiform encephalopathy (BSE), a member of the transmissible spongiform encephalopathies (TSE), primarily affects cattle. Transmission is via concentrate feed rations contaminated with infected meat and bone meal (MBM). In addition to cattle, other food animal species are susceptible to BSE and also pose a potential threat to human health as consumption of infected meat products is the cause of variant Creutzfeldt-Jakob disease in humans, which is invariably fatal. In the UK, farmed and free ranging deer were almost certainly exposed to BSE infected MBM in proprietary feeds prior to legislation banning its inclusion. Therefore, although BSE has never been diagnosed in any deer species, a possible risk to human health remains via ingestion of cervine products. Chronic wasting disease (CWD), also a TSE, naturally infects several cervid species in North America and is spreading rapidly in both captive and free-ranging populations.
Background
Bovine spongiform encephalopathy (BSE), which affects cattle and several other food animal species [1, 2] , belongs to the transmissible spongiform encephalopathy (TSE) group of fatal neurodegenerative diseases affecting humans and animals [3, 4] and can be transmitted within and between species by ingestion or parenteral inoculation [5] . TSEs which include, amongst others, scrapie in sheep and goats, sporadic Creutzfeldt-Jakob disease (CJD) in humans and chronic wasting disease (CWD) of deer [6] are all characterised by long incubation periods leading to clinical neurological manifestations. The pathological changes can usually be linked with the conversion of the normal host-encoded membrane associated prion protein (PrP C ) to abnormal disease-associated isoforms (PrP d ) and their accumulation in the nervous system and, depending on the host species and the TSE agent involved, the lymphoreticular system [7] . Detection of PrP d in tissues by various laboratory methods is the current approach for a definitive diagnosis of any TSE [8] .
Ten years after the first report of BSE in cattle [9] variant Creutzfeldt-Jakob disease (vCJD) was diagnosed in humans in the UK [10] and is invariably fatal [11] . Ingestion of BSE contaminated bovine products was subsequently linked to the development of vCJD [12] resulting in greatly intensified surveillance and research in both humans and food animals [13] .
During the 1980s UK farmed deer were fed relatively large amounts of proprietary concentrate feed containing ruminant derived meat and bone meal (MBM) due to the market demand for well grown breeding stock. Additionally, some free ranging estate deer, park deer and cervids of many different species kept in UK zoological collections were also fed similar proprietary concentrate feed (pers com. Dr. T.J. Fletcher). It is highly unlikely that these concentrates were free from BSE contaminated MBM suggesting that UK deer have been exposed to infectious material. Surveys of several thousand deer brains have so far revealed no evidence of any sub-clinical TSE infection in deer in Europe. This is despite the presence in North America of CWD, a highly infectious TSE which specifically affects deer including the elk (Cervus elaphus nelsoni), a sub-species of European red deer, and is currently the only TSE maintained in free ranging populations [14] . However, the European surveys have either not concentrated on farmed populations, been regionally restricted, had limited numbers or have not specifically targeted clinical neurological suspects [15] [16] [17] [18] [19] [20] .
Results
In the present study 6 European red deer (Cervus elaphus elaphus), the most commonly farmed cervid species in the UK, were challenged intracerebrally (i/c) with BSE positive bovine brain material and a further 2 deer received sterile saline by the same route. All deer on the study were methionine homozygous at codon 132 of the cervid prion protein [21] equivalent to codon 129 in humans [22] . All six BSE-inoculated animals developed a variable range of neurological clinical signs including ataxia, anorexia, circling and apparent blindness along with failure of seasonal change of coat, weight loss and 'panic attacks' between 794-1300 days post-challenge (Table 1) . The panic attacks comprised various episodes of mania of differing severity and duration, which in the first and last animals to develop clinical signs resulted in self trauma requiring euthanasia on welfare grounds. Five of the affected deer were euthanased and one (deer No. 5) died of inhalation pneumonia. With the exception of very little intra-thoracic or abdominal adipose tissue, which was apparent in all animals, gross lesions were present only in the animal that died of inhalation pneumonia. Severe consolidation of the right apical lung lobe was present with red/green discolouration, the tissue was very friable and a low-viscosity purulent material oozed from the cut surface. Also, blood was present in the caecum of this animal.
Spongiform change characterized by vacuolation of both neuronal perikarya and grey matter neuropil was prominent in the brains of all six clinically affected deer ( Figure  1 ). Optically empty, round or oval vacuoles were present in neuropil while neuronal perikaryonal vacuoles were sometimes loculated and sometimes contained membranous debris. The appearance and distribution of the vacuoles are thus indistinguishable from those of other classical TSEs, including CWD. Lesions predominantly affected the brain stem, thalamus and striate body, as well as the molecular layer of the cerebellum and cerebrocortical layers V and VI.
Immunohistochemical labelling of PrP d
Accumulation of PrP d in the BSE infected deer was restricted to the central and peripheral nervous systems, including all levels of the spinal cord, the autonomic ganglia, peripheral and cranial nerves, the enteric nervous system and the sensory retina. Essentially the same neuroanatomic pattern and types of PrP d accumulation were found with each of the two antibodies (F99 and Bar 224) that were used. PrP d deposits were more inconsistent and less intense in the first deer to show clinical signs compared with the other five, possibly due to its shorter incubation period (794 days, Table 1 ). PrP d was found to accumulate in all anatomical areas of the brain though levels were relatively lower in the cerebral cortex. Typically, only grey matter was involved, with the most prominent accumulations being of the fine particulate type, with some more coarse and linear deposits in severely affected areas (Figure 2 ). Granular deposits of PrP d within the cytoplasm of neurons were prominent, especially throughout the brainstem and thalamic nuclei, though they were less conspicuous in the striate body and cerebral cortex. In the cerebellum, accumulation of intra-neuronal PrP d was conspicuous in the deep nuclei and, distinctly, in the Golgi neurons of the granular layer, but not in the Purkinje cells (Figure 3 ). Intracellular deposits of PrP d were also noticeable in astrocytes and microglial cells in areas of heavy neuropil involvement. In the cerebral grey matter, the PrP d around glial cells produced a diffuse stellate pattern of accumulation. Very little PrP d accumulation was present around blood vessels in cerebral white matter or as intra-astrocytic granules in the cerebellum. PrP d was not detected in lymphoreticular tissues, skeletal muscle, kidneys or any of the other organs examined.
Western immunoblotting
Western immunoblot analysis of individual samples of cerebellum from the 6 clinically affected deer using antibody L42 after treatment with proteinase K showed a glycosylation pattern of protease-resistant PrP (PrP res ) in 
f s e a s o n a l c h a n g e o f c o a t - which the di-glycosyl fraction predominated ( Figure 4 and Table 2 ) with some minor variations in labelling intensity between animals. The deer di-, mono-and unglycosylated bands migrated significantly (p < 0.001) further than the corresponding bands in both the cattle and experimental ovine BSE samples, which in turn migrated significantly more than ovine scrapie. None of the BSEinfected samples, irrespective of the species of origin (bovid, ovid or cervid), reacted with antibody P4 in an identical Western immunoblot but the sample of scrapie infected ovine brain did (data not shown). The lack of labelling by antibody P4 is a recognised method of differentiation between ovine BSE and scrapie derived PrP res [23] . Additionally, all cervid samples did label with antibody P4 in the absence of proteinase K treatment indicating that PrP C is detected by this method in all species examined (data not shown). This absence of detection of cervid PrP res after proteinase K treatment by the P4 antibody is consistent with immunoblot characteristics of other experimental ruminant BSE infections and some experimental sheep scrapie sources such as CH1641 [24] .
Discussion
This is the first report of the successful experimental transmission of BSE to any species of deer and the first report of any TSE in European deer. European red deer were chosen because in the UK they are the cervid species most commonly given supplementary proprietary feed under both farmed or free-ranging estate management and therefore are the species most likely to have been exposed to BSE contaminated MBM prior to its exclusion from animal feed. Additionally, they are very closely related to the North American elk which is susceptible to CWD [14] .
The resultant clinical signs in the BSE challenged red deer were similar to those reported in both naturally acquired and experimental CWD in cervids in North America, including death due to secondary inhalation pneumonia [14] . As such, we believe it would not be possible to differentiate BSE, if it occurred naturally, from CWD in deer by routine clinical examination in the field.
The vacuolation pattern found in the brains of the BSE challenged red deer is similar to that reported in cattle with BSE except that the mesencephalon appeared to be more affected in the latter [13] . in BSE yet present in the lymphoid tissue in CWD. However, the red deer in this study were experimentally challenged by the i/c route and we cannot be certain of the distribution of PrP d in deer exposed to natural, presumably oral, challenge with BSE.
Western immunoblot analysis of the brains from the 6 affected red deer showed that the PrP res pattern of i/c cervid BSE has similarities to cattle BSE including a relatively fast migrating aglycosyl band and predominance of the diglycosyl band (Figure 4) . The greater intensity of labelling of deer 5 may be due to it dying, and therefore reaching a terminal end point, rather than a clinical end point where animals were euthanased at an agreed severity of clinical signs, as occurred in the previous four affected deer. Also, deer 5 was the only female in the BSE i/c challenge group, however, we are uncertain if this had any effect on PrP res glycoprofile or levels of accumulation. The significantly (p < 0.001) greater migration of all three protease resistant bands (di-, mono-and unglycosylated) in the red deer samples compared to the cattle and sheep BSE suggests some host adaptation of BSE PrP res propagated within the red deer nervous system. The altered biochemical properties suggests the possibility of alternative truncation of the PrP molecule within deer compared with the bovine or ovine host.
Conclusion
This study shows that European red deer are susceptible to i/c challenge with the BSE agent resulting in a disease that is clinically indistinguishable by routine clinical examination from that reported for CWD [14] . Thus strong measures to prevent the spread of CWD to Europe are essential as even small numbers of CWD cases could result in the need for extensive testing of deer tissues destined for human consumption.
The susceptibility of UK red deer to natural, presumably oral, exposure is still uncertain. The absence of PrP d in lymphoid tissues in the present work might appear to limit the risk to humans of infection from venison and other non-neuronal edible deer tissues and also limits the maintenance of natural infection in the environment. However, the susceptibility of peripheral tissues to infection cannot be ascertained from i/c challenge and must await the outcome of parallel oral challenge experiments.
Methods

Animal procedures
Eight European red deer calves were housed at 1-2 days old, initially hand reared with artificial milk and then given ad-libitum access to water, hay and proprietary concentrated feed when weaned. All experimental protocols Weybridge, UK) diluted in sterile normal (0.9%) saline and containing 1.25 mg/ml ampicillin was inoculated into the right cerebral hemisphere under general anaesthesia (n = 6, 5 castrated males and 1 female, 10-12 months old). Control animals (n = 2, female, 10-12 months old) underwent an identical procedure with sterile normal saline containing 1.25 mg/ml ampicillin. All animals were observed daily for clinical signs of disease and weighed monthly.
Genotyping
Genotyping was performed either from blood samples taken from live deer into vacutainers containing EDTA (BD Bioscience, Erembodegem, Belgium) or from frozen brain material collected post-mortem. DNA was extracted from blood using the CST Genomic DNA Purification Kit (Charge Switch™ Technology, DNA Research Innovations, Ltd., Sittingbourne, UK) and from frozen brain tissue using the DNeasy Blood & Tissue kit (Qiagen, Hilden, Germany) according to manufacturers' instructions. PCR amplification of genomic DNA was carried out using PCR primers C.e. 19fwd 5' ATT TTG CAG ATA AGT CAT C 3' and C.e. 778rev 5' AGA AGA TAA TGA AAA CAG GAA G 3' [21]. The PCR reaction was carried out using a hot start of 95°C, 15 min then 10 cycles of 94°C for 30 sec, 55°C for 30 sec, 72°C for 45 sec then 30 cycles of 95°C for 30 sec, 59°C for 30 sec, 72°C for 59 sec. Amplified samples were then sequenced by the dideoxy chain termination method using ET terminator chemistry using a MegaBACE 500 instrument and Cimarron 3.12 basecaller (GE Healthcare, Amersham plc., Buckinghamshire, UK).
Post-mortem examination
The 6 BSE challenged deer (5 males and 1 female), and 2 clinically normal negative control deer (both female) were subjected to full post-mortem examination and an extensive range of tissue samples taken from: 1) the nervous system (brain and pituitary, cervical, thoracic and lumbar spinal cord with associated dorsal root ganglia, the trigeminal, nodose, stellate and cranial mesenteric ganglia, the vagus nerve, the sympathetic chain, the second muscular branch of the sciatic nerve and the eye), 2) the lymphoreticular system (third eyelid, submandibular, retropharyngeal, prescapular, mediastinal, popliteal and proximal and distal jejunal lymph nodes, the palatine tonsil and spleen), gastro-intestinal tract (oesophagus, omasum, abomasum, duodenum, jejunum, distal ileum and colon all with their associated Payer's patches and the caecum), 3) body fluids (cerebrospinal fluid, blood serum, blood buffy coat and urine), and 4) other tissues (skin of the ventral lip, inter-ventricular septum of the heart, left caudal lung lobe, liver, kidney, semitendinosus muscle and uterus and mammary gland if present). All samples were fixed in 10% neutral buffered formalin and/ or frozen and stored at -80°C. Fixed samples were postfixed in fresh 10% neutral buffered formalin then routinely processed for embedding in paraffin wax. Four μm thick sections were cut and mounted on glass slides (Superfrost Plus; Menzel-Gläser, Braunschweig, Germany) and either stained with haematoxylin and eosin or subjected to IHC.
Immunohistochemical localisation of PrP d
This was performed as previously described 
Statistical analysis of Western immunoblot
Each of the three relevant bands (di-, mono-, and unglycosylated) positive for protease resistant PrP by labelling with antibody L42 on Western immunoblots were analysed separately for distance migrated using a linear mixed model with the type of sample included as a fixed effect in the model and blot included as a random effect in the model. The parameters in the model were estimated using the REML directive in Genstat 10 th edition. Using this model accounts for the differences in mean levels between blots for each type of band separately (as opposed to subtracting off a constant amount from all the readings on one blot to allow for differences between them). The three bands in a single column are not independent of each other and so the results from the three separate analyses are likely to be correlated. Data were available from five replicate Western immunoblots each containing samples representing scrapie, experimental ovine BSE, bovine BSE and the six BSE challenged clinically affected deer (only five samples for i/c challenged deer were present on three of the blots, deer 6 was absent) and the two negative control animals (which did not label for protease resistant PrP). Samples were considered to be significant at p ≤ 0.05.
